Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach.

Brain Commun · 2020 · PMC7677606 · PMID 33241213

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

The difference in ≥75% RR between the PSL and placebo groups approached statistical significance, and there was a notable, nominally significant reduction in weekly seizure frequency.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.